BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 22871617)

  • 1. Prevalence of Xmnl Gγ polymorphism in Egyptian patients with β-thalassemia major.
    Tantawy AA; Andrawes NG; Ismaeil A; Kamel SA; Emam W
    Ann Saudi Med; 2012; 32(5):487-91. PubMed ID: 22871617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of Gγ-globin promoter -158 (C>T) XmnI polymorphism in patients with homozygous/compound heterozygous beta thalassaemia.
    Ali N; Ayyub M; Khan SA; Ahmed S; Abbas K; Malik HS; Tashfeen S
    Hematol Oncol Stem Cell Ther; 2015 Mar; 8(1):10-5. PubMed ID: 25591326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Aγ-globin G->A gene polymorphism associated with β
    Breveglieri G; Bianchi N; Cosenza LC; Gamberini MR; Chiavilli F; Zuccato C; Montagner G; Borgatti M; Lampronti I; Finotti A; Gambari R
    BMC Med Genet; 2017 Aug; 18(1):93. PubMed ID: 28851297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The associations of SEA-alpha thalassemia 1, XmnI-Ggamma polymorphism and beta-globin gene mutations with the clinical severity of beta-thalassemia syndrome in northern Thailand.
    Tatu T; Sritong W; Sa-Nguansermsri T
    J Med Assoc Thai; 2014 Mar; 97(3):300-7. PubMed ID: 25123009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and Functional Insights on an Uncharacterized Aγ-Globin-Gene Polymorphism Present in Four β0-Thalassemia Families with High Fetal Hemoglobin Levels.
    Bianchi N; Cosenza LC; Lampronti I; Finotti A; Breveglieri G; Zuccato C; Fabbri E; Marzaro G; Chilin A; De Angelis G; Borgatti M; Gallucci C; Alfieri C; Ribersani M; Isgrò A; Marziali M; Gaziev J; Morrone A; Sodani P; Lucarelli G; Gambari R; Paciaroni K
    Mol Diagn Ther; 2016 Apr; 20(2):161-73. PubMed ID: 26897028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The correlation of α-globin gene mutations and the XmnI polymorphism with clinical severity of Hb E/β-thalassemia.
    Charoenkwan P; Teerachaimahit P; Sanguansermsri T
    Hemoglobin; 2014; 38(5):335-8. PubMed ID: 25238043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thalassemia Major and Intermedia Patients in East Java do not Show Fetal Hemoglobin Level Difference in Relation to XMNI Polymorphism.
    Wulandari RD; Lyrawati D; Fatchiyah F; Fitri LE
    Med Arch; 2020 Apr; 74(2):90-94. PubMed ID: 32577047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug Repurposing: Hydroxyurea Therapy Improves the Transfusion-Free Interval in HbE/Beta-Thalassemia-Major Patients with the
    Ghosh D; Panja A; Saha D; Banerjee U; Datta AK; Basu A
    Genet Test Mol Biomarkers; 2021 Aug; 25(8):563-570. PubMed ID: 34406845
    [No Abstract]   [Full Text] [Related]  

  • 9. Association of Xmn1 -158 γG variant with severity and HbF levels in β-thalassemia major and sickle cell anaemia.
    Dadheech S; Jain S; Madhulatha D; Sharma V; Joseph J; Jyothy A; Munshi A
    Mol Biol Rep; 2014 May; 41(5):3331-7. PubMed ID: 24488321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study on the genotype frequency of -158 Gγ (C→T)
    Moez P; Moftah R; Mahmoud HA
    J Genet; 2018 Jun; 97(2):505-511. PubMed ID: 29932071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic factors affecting clinical severity in beta-thalassemia syndromes.
    Winichagoon P; Fucharoen S; Chen P; Wasi P
    J Pediatr Hematol Oncol; 2000; 22(6):573-80. PubMed ID: 11132233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Swiss-type heterocellular HPFH from XmnI-Gγ and HBBP1 polymorphisms on HbF, HbE, MCV and MCH levels in Thai HbE carriers.
    Kerdpoo S; Limweeraprajak E; Tatu T
    Int J Hematol; 2014 Mar; 99(3):338-44. PubMed ID: 24474642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The molecular characterization of Beta globin gene in thalassemia patients reveals rare and a novel mutations in Pakistani population.
    Yasmeen H; Toma S; Killeen N; Hasnain S; Foroni L
    Eur J Med Genet; 2016 Aug; 59(8):355-62. PubMed ID: 27263053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Xmn1 polymorphic site 5' to the (G)gamma gene and its correlation to the (G)gamma:(A)gamma ratio, age at first blood transfusion and clinical features in beta-thalassemia patients from Western Iran.
    Nemati H; Rahimi Z; Bahrami G
    Mol Biol Rep; 2010 Jan; 37(1):159-64. PubMed ID: 19444645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Featured Article: Modulation of fetal hemoglobin in hereditary persistence of fetal hemoglobin deletion type-2, compared to Sicilian δβ-thalassemia, by BCL11A and SOX6-targeting microRNAs.
    Fornari TA; Lanaro C; Albuquerque DM; Ferreira R; Costa FF
    Exp Biol Med (Maywood); 2017 Feb; 242(3):267-274. PubMed ID: 27591578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectrum of beta thalassemia mutations and HbF levels in the heterozygous Moroccan population.
    Lemsaddek W; Picanço I; Seuanes F; Mahmal L; Benchekroun S; Khattab M; Nogueira P; Osório-Almeida L
    Am J Hematol; 2003 Jul; 73(3):161-8. PubMed ID: 12827652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between clinical expression and molecular heterogeneity in β-thalassemia Tunisian patients.
    Jouini L; Sahli CA; Laaouini N; Ouali F; Ben Youssef I; Dakhlaoui B; Othmeni R; Ouennich F; Hadj Fredj S; Siala H; Becher M; Toumi NE; Fattoum S; Hafsia R; Bibi A; Messaoud T
    Mol Biol Rep; 2013 Nov; 40(11):6205-12. PubMed ID: 24065537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of Gγ-158(C→T) polymorphism in hemoglobin E/β-thalassemia major in Southern China.
    Liu RR; Wang MY; Lai YR
    J Hematol Oncol; 2010 Sep; 3():29. PubMed ID: 20822527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between BCL11A, HSB1L-MYB, and XmnI γG-158 (C/T) gene polymorphism and hemoglobin F level in Egyptian sickle cell disease patients.
    El-Ghamrawy M; Yassa ME; Tousson AMS; El-Hady MA; Mikhaeil E; Mohamed NB; Khorshied MM
    Ann Hematol; 2020 Oct; 99(10):2279-2288. PubMed ID: 32772141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gγ-Xmn I polymorphism: a significant determinant of β-thalassemia treatment without blood transfusion.
    Ansari SH; Shamsi TS; Munzir S; Khan MT; Erum S; Perveen K; Farzana T; Ashraf M; Mehboob T; Moinuddin M
    J Pediatr Hematol Oncol; 2013 May; 35(4):e153-6. PubMed ID: 23389500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.